In this video, Ian Bouligny, MD, discusses his team’s research that aimed to determine the impact of secondary-type mutations in patients who were newly diagnosed with acute myeloid leukemia and treated...
In this video, Kendall Diebold, DNP, FNP-C, speaks about her team’s research titled “Outcomes of 3- Versus 5-Day Administration Schedule of Consolidation Cytarabine in Adults with Acute Myeloid Leukemia,”...
In this video, Hector R. Villarraga, MD, discusses the long-term incidence of heart failure in patients with breast cancer or lymphoma treated with anthracycline therapy and the clinical impact of his...
In this video, Paolo Strati, MD, discusses chemotherapy-free approaches in the treatment of patients with indolent b-cell lymphoma, including early trials that are underway on the combination of...
This video highlights the current guideline recommendations for treating early breast cancer as well as the current guidelines for metastatic breast cancer.
In this video, Brittany A. Davidson, MD, discusses navigating goals-of-care conversations in gynecologic oncology, including how to identify patients at high risk of death who might benefit from a timely...
In this video, Stephanie V. Blank, MD, and Warner K. Huh, MD, discuss the evolving role of the gynecologic oncologist, including the use of chemotherapy, benign surgery, and the management of patients with...
Michael Banks, MD, discusses a recent study in which Danish researchers used urine from cancer patients to detect mutations common in bladder cancer. The test was shown to detect cancer with 97%...
Jeff Hutchins, PhD, discusses current clinical trials that are investigating whether some patients with non-small cell lung cancer may qualify for an immune-oncology therapy treatment regimen that is...
Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only be effective...
